Major adverse kidney events in multidisciplinary chronic kidney disease care compared with usual outpatient care: a

Palita Chittinandana1, Pongsathorn Gojaseni2, Anan Chuasuwan1

  • 1Division of Nephrology, Department of Medicine, Bhumibol Adulyadej Hospital, Royal Thai Air Force, Bangkok, Thailand.

Journal of Nephrology
|June 28, 2024
PubMed

Insights

Multidisciplinary CKD care significantly reduced major adverse kidney events and mortality in patients with stages G3b-4 chronic kidney disease (CKD). This approach, especially for diabetes mellitus patients, improved kidney outcomes compared to usual care.

Area of Science:

  • Nephrology
  • Public Health
  • Clinical Medicine

Background:

  • Chronic kidney disease (CKD) is a global health concern requiring effective management strategies.
  • Multidisciplinary care is recommended for CKD to slow progression and reduce complications, but its impact on major adverse kidney events remains unclear.

Purpose of the Study:

  • To evaluate the effectiveness of multidisciplinary CKD care (MDC) versus usual outpatient care (UOC) on major adverse kidney events in CKD patients.
  • To assess the impact of MDC on kidney function decline, mortality, and hospitalization rates.

Main Methods:

  • A cohort study included patients with CKD stages G3b-4 from 2014-2020.
  • Propensity score matching was used to compare MDC and UOC groups based on key clinical factors.
  • The primary outcome was a composite of cardiovascular or renal mortality, 40% eGFR decline, or initiation of kidney replacement therapy.

Main Results:

  • After matching, 822 patients (mean age 70.9 years, 64% with diabetes) were analyzed.
  • MDC significantly lowered the primary endpoint rate (24.1% vs. 38.9%, HR 0.66) and 40% eGFR decline (21.7% vs. 35.0%, HR 0.67).
  • MDC also reduced all-cause mortality (8.5% vs. 19.5%, HR 0.60) and hospitalizations per year (P < 0.001), with enhanced benefits for diabetes patients.

Conclusions:

  • Multidisciplinary CKD care demonstrates significant benefits for kidney outcomes in patients with CKD stages G3b-4 compared to usual outpatient care.
  • The positive effects of MDC were particularly pronounced in patients with diabetes mellitus.
  • These findings support the implementation of multidisciplinary care models for managing advanced CKD.
Abstract

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
79
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
81
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
288
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
362
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.3K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419